# EDGAR Filing Document

**Accession Number:** 0001931373
**File Stem:** 0001096906-23-000475
**Filing Date:** 2023-3
**Character Count:** 2769
**Document Hash:** 79c0210f279e81543a3cd029f66ed6cc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001096906-23-000475.hdr.sgml**: 20230302

**ACCESSION NUMBER**: 0001096906-23-000475

**CONFORMED SUBMISSION TYPE**: RW

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230302

**DATE AS OF CHANGE**: 20230302

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PSLY.COM, Inc.
- **CENTRAL INDEX KEY:** 0001931373
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 882438737
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** RW

**SEC ACT:**
- **SEC FILE NUMBER:** 333-267027
- **FILM NUMBER:** 23697305

**BUSINESS ADDRESS:**
- **STREET 1:** 20533 BISCAYNE BLVD.
- **STREET 2:** STE 4-616
- **CITY:** AVENTURA
- **STATE:** FL
- **ZIP:** 33180
- **BUSINESS PHONE:** 310-948-9977

**MAIL ADDRESS:**
- **STREET 1:** 20533 BISCAYNE BLVD.
- **STREET 2:** STE 4-616
- **CITY:** AVENTURA
- **STATE:** FL
- **ZIP:** 33180

**PSLY.com, Inc.**

**1215 S. Kihei Road Ste O PMB 424** 

**Kihei, Hawaii 96753**

March 2, 2023

**VIA EDGAR**

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jordan Nimitz

Attention: Laura Crotty

---

| | |
|:---|:---|
| **Re:** | **PSLY.com, Inc.** |
|  | **Request for Withdrawal of Registration Statement on Form S-4** |
|  | **File No 333-267027**  |

---

Dear Ms. Nimitz and Ms. Crotty:

Pursuant to Rule 477 of the Securities Act of 1933, as amended (the "*Securities Act*"), PSLY.com, Inc. (the "*Company*") hereby respectfully requests that the Company's Registration Statement on Form S-4 (File No. 333-267027), together with all exhibits thereto, and as subsequently amended from time to time (the "*Registration Statement*"), initially filed with the Securities and Exchange Commission (the "*Commission*") on November 4, 2022, be withdrawn, effective as of the date hereof. The Company is withdrawing the Registration Statement because it no longer plans to consummate the business combination described in the Registration Statement, and hereby confirms that no securities registered under the Registration Statement have been sold.

The Company requests that, in accordance with Rule 457(p) of the Securities Act and subject to compliance with the requirements thereof, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for potential future use.

Please contact Lawrence Bard, Esq. (301-945-9242) or Hunter Haines, Esq. (301-945-9284) at Shulman Rogers, P.A. if you have any other questions or concerns regarding this matter.

---

| |
|:---|
| Sincerely, |
| /s/ David Nikzad |
| David Nikzad |
| *Chief Executive Officer* |

---